- Home
- SIBN vs SIGA Comparison
SIBN vs SIGA Comparison
Compare SIBN & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIBN
- SIGA
- Stock Information
- Founded
- SIBN 2008
- SIGA 1995
- Country
- SIBN United States
- SIGA United States
- Employees
- SIBN N/A
- SIGA N/A
- Industry
- SIBN Medical/Dental Instruments
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- SIBN Health Care
- SIGA Health Care
- Exchange
- SIBN Nasdaq
- SIGA Nasdaq
- Market Cap
- SIBN 606.1M
- SIGA 594.3M
- IPO Year
- SIBN 2018
- SIGA 1997
- Fundamental
- Price
- SIBN $19.67
- SIGA $5.84
- Analyst Decision
- SIBN Strong Buy
- SIGA
- Analyst Count
- SIBN 5
- SIGA 0
- Target Price
- SIBN $24.60
- SIGA N/A
- AVG Volume (30 Days)
- SIBN 668.4K
- SIGA 466.5K
- Earning Date
- SIBN 11-10-2025
- SIGA 11-06-2025
- Dividend Yield
- SIBN N/A
- SIGA 10.40%
- EPS Growth
- SIBN N/A
- SIGA N/A
- EPS
- SIBN N/A
- SIGA 1.03
- Revenue
- SIBN $193,578,000.00
- SIGA $172,249,641.00
- Revenue This Year
- SIBN $19.94
- SIGA N/A
- Revenue Next Year
- SIBN $16.48
- SIGA $115.06
- P/E Ratio
- SIBN N/A
- SIGA $5.67
- Revenue Growth
- SIBN 23.27
- SIGA N/A
- 52 Week Low
- SIBN $11.70
- SIGA $4.95
- 52 Week High
- SIBN $20.05
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- SIBN 76.39
- SIGA 23.55
- Support Level
- SIBN $16.74
- SIGA $5.80
- Resistance Level
- SIBN $19.47
- SIGA $6.05
- Average True Range (ATR)
- SIBN 0.98
- SIGA 0.33
- MACD
- SIBN 0.31
- SIGA -0.11
- Stochastic Oscillator
- SIBN 92.09
- SIGA 5.45
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.